Despite ongoing issues with medication quality in public health facilities, a well-known local company is planning to manufacture drugs in Eswatini. The aspiring manufacturer is Avapharm, a ...

Drugmaker Viatris beat Wall Street estimates for third-quarter profit and revenue on Thursday, helped by strong demand for its new generic asthma and ADHD drugs, among others, sending its shares up 2.

Viatris (NASDAQ:VTRS) shares reached the highest level since late February on Thursday after the maker of the anxiety drug ...

The Nasal Drug Delivery Technology Market is driven by the rising demand for non-invasive administration methods that enhance patient compliance and bioavailability. Innovations such as advanced ...

A new focus on dermatology, ophthalmology, and gastroenterology will pave ways for many untapped opportunities that Viatris can utilize with its scale and manufacturing power. We believe Viatris is in ...

GATC West Virginia is making progress in medical innovation at its headquarters in the WVU Innovation Corp. Their lab is up ...

ALK will also pay up to $320m in milestone payments to ARS in the deal, which sees the latter keep rights in the US, ...

Pharmaceutical company Viatris (VTRS 13.52%) reported third-quarter 2024 financial results on Thursday, Nov. 7, that topped ...

The prefilled syringe drug molecule market is set for significant expansion, with projected sales increasing from USD ...

“The global short-acting beta-agonists market is witnessing unprecedented growth driven by advancements in drug development ...

A suit against Novartis and Vitaris by Henrietta Lacks’ estate hinges on questions about the morality and legality of using ...

The global oral controlled release drug delivery technology market is on track for significant expansion, with projections estimating its market value to soar from USD 34.1 billion in 2022 to USD 68.4 ...